These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Haematological cancer: Prophylactic platelet transfusion is frequently not necessary. Schiffer CA Nat Rev Clin Oncol; 2013 Aug; 10(8):431-2. PubMed ID: 23820637 [No Abstract] [Full Text] [Related]
9. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G; Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506 [TBL] [Abstract][Full Text] [Related]
10. Platelet transfusions for patients with haematological malignancies: who needs them? Estcourt LJ; Stanworth SJ; Murphy MF Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375 [TBL] [Abstract][Full Text] [Related]
11. [Thrombocytopenia: is therapeutic platelet transfusion effective? Prophylactic platelet transfusion remains justified]. Bethge W Dtsch Med Wochenschr; 2012 Dec; 137(50):2630. PubMed ID: 23225185 [No Abstract] [Full Text] [Related]
12. Clarify the negatives of the MIRASOL noninferiority trial. Strauss RG Transfusion; 2011 Jun; 51(6):1361-2; author reply 1362-4. PubMed ID: 21658043 [No Abstract] [Full Text] [Related]
13. [Prophylactic platelet transfusion in patients with hematologic diseases]. Siitonen T; Koistinen P Duodecim; 2004; 120(7):877-84. PubMed ID: 15154309 [No Abstract] [Full Text] [Related]
14. Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: a retrospective analysis of count increment, corrected count increment and transfusion interval. Cid J; Ramiro L; Escoda L; Llorente A Vox Sang; 2009 Jan; 96(1):29-33. PubMed ID: 19121195 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic platelet transfusion for hypoproliferative thrombocytopenia. Takahashi Y; Nishikawa Y; Mori J; Hamaki T; Tanimoto T Lancet; 2013 Mar; 381(9868):724. PubMed ID: 23472915 [No Abstract] [Full Text] [Related]
16. Therapeutic platelet transfusion for hypoproliferative thrombocytopenia. Tsuda K; Morita T; Tsubokura M; Matsumura T; Kami M Lancet; 2013 Mar; 381(9868):723-4. PubMed ID: 23472914 [No Abstract] [Full Text] [Related]
18. Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience. Gurevich-Shapiro A; Tzadok S; Rosenberg A; Inbal A; Bar-Natan M; Wolach O; Raanani P Acta Haematol; 2017; 137(4):183-190. PubMed ID: 28419992 [TBL] [Abstract][Full Text] [Related]
19. A consistent approach to platelet transfusion in the NICU. Del Vecchio A; Motta M; Radicioni M; Christensen RD J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME). Wiita AP; Nambiar A Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]